No shortage on file

CAELYX

BAXTER CORPORATION

Quick answers

Is there a shortage of CAELYX in Canada?

No. There is no current shortage of CAELYX 2MG reported to Health Canada. Stock can still vary from one pharmacy to another.

Can I still get this?No shortage reported — confirm local stock with your pharmacy

StatusNo shortage on file

Same-ingredient products on file6 products

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Closest Matches

PEGYLATED LIPOSOMAL DOXORUBICIN HYDROCHLORIDE FOR INJECTION

DR REDDY'S LABORATORIES LTD

2MG · DIN 02544857

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

TARO-DOXORUBICIN LIPOSOMAL

TARO PHARMACEUTICALS INC

2MG · DIN 02493020

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

Other Products

ADRIAMYCIN PFS

PFIZER CANADA ULC

2MG · DIN 02071002

Same strengthDifferent dosage formDifferent routeNo current shortage

Compare these two →

DOXORUBICIN HYDROCHLORIDE INJECTION

NOVOPHARM LIMITED

2MG · DIN 02230108

Same strengthDifferent dosage formSame routeNo current shortage

Compare these two →

MYOCET

SOPHERION THERAPEUTICS LLC

2MG · DIN 02245015

Same strengthDifferent dosage formSame routeNo current shortage

Compare these two →

DOXORUBICIN HYDROCHLORIDE INJECTION, USP

STRIDES PHARMA CANADA INC

2MG · DIN 02413973

Same strengthDifferent dosage formDifferent routeNo current shortage

Compare these two →

DIN

02238389

Strength

2MG

Dosage Form

SUSPENSION

Route

INTRAVENOUS

Active Ingredient

DOXORUBICIN HYDROCHLORIDE

See all DOXORUBICIN HYDROCHLORIDE products →

Compare with another product →

Product Monograph

Official Product Monograph (Health Canada)

View official Health Canada drug record ↗

Shortage History

2026-01-07

Shortage Avoided

Disruption of the manufacture of the drug.

Other Products from BAXTER CORPORATION

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

(20 MMOL/L) POTASSIUM CHLORIDE IN 3.3% DEXTROSE AND 0.3% SODIUM CHLORIDE INJECTION USP

DIN 00438014

(20 MMOL/L) POTASSIUM CHLORIDE IN 5% DEXTROSE AND 0.9% SODIUM CHLORIDE INJECTION USP

DIN 00786292

(20 MMOL/L) POTASSIUM CHLORIDE IN 5% DEXTROSE INJECTION USP

DIN 00438049

(20MMOL/L) POTASSIUM CHLORIDE IN 0.9% SODIUM CHLORIDE INJECTION USP

DIN 00786209

(20MMOL/L) POTASSIUM CHLORIDE IN 5% DEXTROSE AND 0.45% SODIUM CHLORIDE INJECTION USP

DIN 00437999

(40 MMOL/L) POTASSIUM CHLORIDE IN 0.9% SODIUM CHLORIDE INJECTION USP

DIN 00786217